| |
Patents issued citing the technology of Innovative Research of America, Inc.
Records 1 - 20 of 1802
| US Patent: | 2008/0114070 |
| Institution(s): | A & G PHARMACEUTICAL, INC. |
| Title: | COMPOSITIONS AND METHODS FOR RESTORING SENSITIVITY OF TUMOR CELLS TO ANTITUMOR THERAPY AND INDUCING APOPTOSIS |
| Inventor(s): | SERRERO |
| Product(s): |
17β-ESTRADIOL (stock); TAMOXIFEN (FREE BASE) (stock) |
| Country/Countries: | USA |
| Date: | 5/15/2008 |
|
| US Patent: | 7,368,428 |
| Institution(s): | A & G PHARMACEUTICAL, INC. |
| Title: | COMPOSITIONS AND METHODS FOR RESTORING SENSITIVITY OF TUMOR CELLS TO ANTITUMOR THERAPY AND INDUCING APOPTOSIS |
| Inventor(s): | SERRERO |
| Product(s): |
17β-ESTRADIOL (stock); TAMOXIFEN (FREE BASE) (stock) |
| Country/Countries: | USA |
| Date: | 5/6/2008 |
|
| US Patent: | 2018/0057588 |
| Institution(s): | AARHUS UNIVERSITET |
| Title: | ANTIBODIES TOWARDS AN EXTRACELLULAR REGION OF NBCN1 |
| Inventor(s): | BODTKJER |
| Product(s): |
MEDROXYPROGESTERONE ACETATE (MPA) / 90 Day (stock) |
| Country/Countries: | DENMARK |
| Date: | 3/1/2018 |
|
| US Patent: | 2019/0085074 |
| Institution(s): | AARHUS UNIVERSITET |
| Title: | ANTIBODIES TOWARDS AN EXTRACELLULAR REGION OF NBCN1 |
| Inventor(s): | BODTKJER |
| Product(s): |
MEDROXYPROGESTERONE ACETATE (MPA) / 90 Day (stock) |
| Country/Countries: | DENMARK |
| Date: | 3/21/2019 |
|
| US Patent: | 8,313,745 |
| Institution(s): | ABBOTT BIOTHERAPEUTICS CORP. |
| Title: | COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF |
| Inventor(s): | MACK, GISH |
| Product(s): |
17β-ESTRADIOL (stock) |
| Country/Countries: | USA |
| Date: | 11/20/2012 |
|
| US Patent: | 2013/0338228 |
| Institution(s): | ABBOTT LABORATORIES |
| Title: | METHODS FOR FACILITATING MUSCLE RECOVERY AFTER A PERIOD OF DISUSE USING BETA-HYDROXY-BETA-METHYLBUTYRATE |
| Inventor(s): | PEREIRA, EDENS |
| Product(s): |
5-BROMO-2'-DEOXYURIDINE (BrDU) / 21 Day (stock) |
| Country/Countries: | USA |
| Date: | 12/19/2013 |
|
| US Patent: | 2014/0037540 |
| Institution(s): | ABBVIE BIOTHERAPEUTICS INC. |
| Title: | COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF |
| Inventor(s): | LAW, GISH |
| Product(s): |
17β-ESTRADIOL (stock) |
| Country/Countries: | USA |
| Date: | 2/6/2014 |
|
| US Patent: | 8,591,863 |
| Institution(s): | ABBVIE BIOTHERAPEUTICS INC. |
| Title: | COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF |
| Inventor(s): | LAW, GISH |
| Product(s): |
17β-ESTRADIOL (stock) |
| Country/Countries: | USA |
| Date: | 11/26/2013 |
|
| US Patent: | 8,906,342 |
| Institution(s): | ABBVIE BIOTHERAPEUTICS INC. |
| Title: | COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF |
| Inventor(s): | LAW, GISH |
| Product(s): |
17β-ESTRADIOL (stock) |
| Country/Countries: | USA |
| Date: | 12/9/2014 |
|
| US Patent: | 2009/0220589 |
| Institution(s): | ABRAXIS BIOSCIENCE, LLC |
| Title: | TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS |
| Inventor(s): | TRIEU, HWANG, DESAI |
| Product(s): |
TAMOXIFEN (FREE BASE) / 30 Day (stock); TAMOXIFEN (FREE BASE) / 45 Day (stock); TAMOXIFEN (FREE BASE) / 60 Day (stock); TAMOXIFEN (FREE BASE) / 90 Day (stock) |
| Country/Countries: | USA |
| Date: | 9/3/2009 |
|
| US Patent: | 2016/0274121 |
| Institution(s): | ACADEMIA SINICA |
| Title: | CANCER MARKERS AND METHODS OF USE THEREOF |
| Inventor(s): | WONG, WU, CHEUNG, CHUANG, HSU |
| Product(s): |
17β-ESTRADIOL / 90 Day (stock) |
| Country/Countries: | TAIWAN |
| Date: | 9/22/2016 |
|
| US Patent: | 2017/0283878 |
| Institution(s): | ACADEMIA SINICA |
| Title: | MODULATION OF GLOBOSERIES GLYCOSPHINGOLIPID SYNTHESIS AND CANCER BIOMARKERS |
| Inventor(s): | WONG, WU, CHEUNG, CHUANG, HSU |
| Product(s): |
17β-ESTRADIOL / 90 Day (stock) |
| Country/Countries: | TAIWAN |
| Date: | 10/5/2017 |
|
| US Patent: | 2009/0304691 |
| Institution(s): | ACCELERON PHARMA INC. |
| Title: | ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF |
| Inventor(s): | SEEHRA, KNOPF, PEARSALL, GRINBERG, KUMAR |
| Product(s): |
17β-ESTRADIOL (stock) |
| Country/Countries: | USA |
| Date: | 12/10/2009 |
|
| US Patent: | 2013/0039910 |
| Institution(s): | ACCELERON PHARMA, INC. |
| Title: | METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION |
| Inventor(s): | GRINBERG, KNOPF, KUMAR, PEARSALL, SEEHRA, PIETRAS |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | USA, SWEDEN |
| Date: | 2/14/2013 |
|
| US Patent: | 2013/0040896 |
| Institution(s): | ACCELERON PHARMA, INC. |
| Title: | METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION |
| Inventor(s): | GRINBERG, KNOPF, KUMAR, PEARSALL, SEEHRA, PIETRAS |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | USA, SWEDEN |
| Date: | 2/14/2013 |
|
| US Patent: | 2014/0193425 |
| Institution(s): | ACCELERON PHARMA, INC. |
| Title: | TREATMENT OF CANCER WITH ALK1 ANTAGONISTS |
| Inventor(s): | KNOPF, KUMAR, PEARSALL, SHERMAN |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | USA |
| Date: | 7/10/2014 |
|
| US Patent: | 2014/0227254 |
| Institution(s): | ACCELERON PHARMA, INC. |
| Title: | ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF |
| Inventor(s): | SEEHRA, KNOPF, PEARSALL, GRINBERG, KUMAR |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | USA |
| Date: | 8/14/2014 |
|
| US Patent: | 8,642,031 |
| Institution(s): | ACCELERON PHARMA, INC. |
| Title: | ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF |
| Inventor(s): | SEEHRA, KNOPF, PEARSALL, GRINBERG, KUMAR |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | USA |
| Date: | 2/4/2014 |
|
| US Patent: | 8,158,584 |
| Institution(s): | ACCELERON PHARMA, INC., LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. |
| Title: | PHARMACEUTICAL PREPARATIONS COMPRISING AN ALK1-FC FUSION PROTEIN |
| Inventor(s): | GRINBERG, KNOPF, KUMAR, PEARSALL, SEEHRA, PEITRAS |
| Product(s): |
17β-ESTRADIOL / 60 Day (stock) |
| Country/Countries: | SWEDEN, USA |
| Date: | 4/17/2012 |
|
| US Patent: | 2006/0263339 |
| Institution(s): | ACTX INC. |
| Title: | RECOVERY OF TISSUE FUNCTION FOLLOWING ADMINISTRATION OF B CELLS TO INJURED TISSUE |
| Inventor(s): | POZNANSKY, GOODCHILD, UNGS, CHRONOS, WEICH |
| Product(s): |
5-BROMO-2'-DEOXYURIDINE (BrDU) (stock) |
| Country/Countries: | USA |
| Date: | 11/23/2012 |
|
|
|
